BMY logo

Bristol-Myers Squibb (BMY) Working Capital

Annual Working Capital

$9.51 B
+$4.13 B+76.63%

December 31, 2023

Summary

Performance

1-Year Change

+76.63%

3-Year Change

-14.43%

5-Year Change

+34.64%

15-Year Change

+79.7%

BMY Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.52%
BMY annual working capital is higher than 99.52% of companies in Healthcare sector

High & Low

All-time High

$11.39 B
BMY annual working capital is currently -16.55% below its historical high of $11.39 billion

3-Year Low

$5.38 B
BMY annual working capital is currently +76.63% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BMY previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
BMY next annual earnings announcement has not yet been scheduled

OtherBMYbalance sheetmetrics:

Annual Book Value

$29.43 B
BMY annual book value is $29.43 billion

Annual Retained Earnings

$28.77 B
BMY annual retained earnings is $28.77 billion

Annual Total Assets

$95.16 B
BMY annual total assets is $95.16 billion

Annual Total Liabilities

$65.67 B
BMY annual total liabilities is $65.67 billion

Quarterly Working Capital

$5.44 B
+$1.81 B+49.99%

September 30, 2024

Summary

Performance

3-Month Change

+49.99%

1-Year Change

-42.82%

3-Year Change

-42.82%

5-Year Change

-42.82%

BMY Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

98.86%
BMY quarterly working capital is higher than 98.86% of companies in Healthcare sector

High & Low

All-time High

$29.70 B
BMY quarterly working capital is currently -81.69% below its historical high of $29.70 billion

3-Year Low

$2.85 B
BMY quarterly working capital is currently +90.97% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BMY previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
BMY next earnings announcement has not yet been scheduled

OtherBMYbalance sheetmetrics:

Quarterly Book Value

$17.14 B
BMY quarterly book value is $17.14 billion

Quarterly Retained Earnings

$16.10 B
BMY quarterly retained earnings is $16.10 billion

Quarterly Total Assets

$93.67 B
BMY quarterly total assets is $93.67 billion

Quarterly Total Liabilities

$76.47 B
BMY quarterly total liabilities is $76.47 billion

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

Annual Working Capital

$9.51 B
BMY annual working capital is $9.51 billion

Annual Current Assets

$11.46 B
BMY annual total current assets is $11.46 billion

Annual Current Liabilities

$22.26 B
BMY annual total current liabilities is $22.26 billion

BMY Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+76.6%-42.8%
3 y3 years-14.4%-42.8%
5 y5 years+34.6%-42.8%

BMY Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-16.6%+76.6%-52.3%+91.0%
5 y5-year-16.6%+76.6%-60.6%+91.0%
alltimeall time-16.6%+665.5%-81.7%+402.0%

Bristol-Myers Squibb Working Capital History

DateAnnualQuarterly
Sep 2024
-
$5.44 B(+50.0%)
Jun 2024
-
$3.63 B(+27.3%)
Mar 2024
-
$2.85 B(-70.1%)
Dec 2023
$9.51 B(+76.6%)
$9.51 B(+128.0%)
Sep 2023
-
$4.17 B(-47.4%)
Jun 2023
-
$7.92 B(-1.0%)
Mar 2023
-
$8.00 B(+48.6%)
Dec 2022
$5.38 B(-52.8%)
$5.38 B(-31.6%)
Sep 2022
-
$7.87 B(-15.2%)
Jun 2022
-
$9.27 B(+27.0%)
Mar 2022
-
$7.30 B(-35.9%)
Dec 2021
$11.39 B(+2.5%)
$11.39 B(+14.1%)
Sep 2021
-
$9.98 B(-1.8%)
Jun 2021
-
$10.17 B(+4.0%)
Mar 2021
-
$9.78 B(-12.0%)
Dec 2020
$11.11 B(+0.6%)
$11.11 B(-19.6%)
Sep 2020
-
$13.81 B(+26.5%)
Jun 2020
-
$10.92 B(-13.5%)
Mar 2020
-
$12.62 B(+14.2%)
Dec 2019
$11.05 B(+56.5%)
$11.05 B(-62.8%)
Sep 2019
-
$29.70 B(+6.1%)
Jun 2019
-
$28.00 B(+239.4%)
Mar 2019
-
$8.25 B(+16.9%)
Dec 2018
$7.06 B(+33.5%)
$7.06 B(+36.5%)
Sep 2018
-
$5.17 B(+29.5%)
Jun 2018
-
$4.00 B(-20.5%)
Mar 2018
-
$5.03 B(-5.0%)
Dec 2017
$5.29 B(+8.8%)
$5.29 B(-5.7%)
Sep 2017
-
$5.61 B(+5.7%)
Jun 2017
-
$5.31 B(+3.6%)
Mar 2017
-
$5.12 B(+5.3%)
Dec 2016
$4.86 B(+102.8%)
$4.86 B(+15.6%)
Sep 2016
-
$4.21 B(-4.6%)
Jun 2016
-
$4.41 B(+22.0%)
Mar 2016
-
$3.62 B(+50.9%)
Dec 2015
$2.40 B(-61.0%)
$2.40 B(-58.4%)
Sep 2015
-
$5.77 B(+2.6%)
Jun 2015
-
$5.62 B(-22.3%)
Mar 2015
-
$7.24 B(+17.7%)
Dec 2014
$6.15 B(-5.1%)
$6.15 B(+1.2%)
Sep 2014
-
$6.07 B(-3.0%)
Jun 2014
-
$6.26 B(-3.5%)
Mar 2014
-
$6.49 B(+0.3%)
Dec 2013
$6.48 B(+421.4%)
$6.48 B(+175.8%)
Sep 2013
-
$2.35 B(+10.1%)
Jun 2013
-
$2.13 B(+28.3%)
Mar 2013
-
$1.66 B(+33.8%)
Dec 2012
$1.24 B(-83.5%)
$1.24 B(+14.7%)
Sep 2012
-
$1.08 B(-73.1%)
Jun 2012
-
$4.02 B(-11.7%)
Mar 2012
-
$4.55 B(-39.6%)
Dec 2011
$7.54 B(+15.4%)
$7.54 B(-0.2%)
Sep 2011
-
$7.56 B(+2.6%)
Jun 2011
-
$7.37 B(+12.6%)
Mar 2011
-
$6.54 B(+0.1%)
Dec 2010
$6.53 B(-14.5%)
$6.53 B(-7.6%)
Jun 2010
-
$7.08 B(+8.6%)
Mar 2010
-
$6.51 B(-14.8%)
Dec 2009
$7.64 B(-4.3%)
$7.64 B(+27.5%)
Sep 2009
-
$6.00 B(-23.4%)
Jun 2009
-
$7.83 B(-10.5%)
Mar 2009
-
$8.74 B(+9.5%)
Dec 2008
$7.99 B(+368.7%)
$7.99 B(+2.0%)
Sep 2008
-
$7.83 B(+86.6%)
Jun 2008
-
$4.20 B(+96.4%)
Mar 2008
-
$2.14 B(+25.4%)
Dec 2007
$1.70 B(-55.2%)
$1.70 B(-33.0%)
Sep 2007
-
$2.54 B(-47.6%)
Jun 2007
-
$4.86 B(+14.2%)
Mar 2007
-
$4.25 B(+11.7%)
DateAnnualQuarterly
Dec 2006
$3.81 B(-29.4%)
$3.81 B(-30.6%)
Sep 2006
-
$5.48 B(-8.2%)
Jun 2006
-
$5.97 B(+7.0%)
Mar 2006
-
$5.58 B(+3.5%)
Dec 2005
$5.39 B(+8.8%)
$5.39 B(+53.1%)
Sep 2005
-
$3.52 B(+29.3%)
Jun 2005
-
$2.73 B(-43.3%)
Mar 2005
-
$4.81 B(-3.0%)
Dec 2004
$4.96 B(+9.3%)
$4.96 B(+3.3%)
Sep 2004
-
$4.80 B(+1.5%)
Jun 2004
-
$4.72 B(-8.8%)
Mar 2004
-
$5.18 B(+14.2%)
Dec 2003
$4.54 B(+188.4%)
$4.54 B(+20.8%)
Sep 2003
-
$3.75 B(+68.4%)
Jun 2003
-
$2.23 B(+0.4%)
Mar 2003
-
$2.22 B(+41.2%)
Dec 2002
$1.57 B(-26.5%)
$1.57 B(-35.4%)
Sep 2002
-
$2.44 B(-23.6%)
Jun 2002
-
$3.19 B(+1.8%)
Mar 2002
-
$3.13 B(+46.4%)
Dec 2001
$2.14 B(-49.0%)
$2.14 B(-11.8%)
Sep 2001
-
$2.43 B(-43.0%)
Jun 2001
-
$4.26 B(+0.1%)
Mar 2001
-
$4.25 B(+1.5%)
Dec 2000
$4.19 B(+12.4%)
$4.19 B(+1.9%)
Sep 2000
-
$4.11 B(+8.0%)
Jun 2000
-
$3.81 B(+2.1%)
Mar 2000
-
$3.73 B(-0.0%)
Dec 1999
$3.73 B(+24.7%)
$3.73 B(+4.9%)
Sep 1999
-
$3.56 B(+8.1%)
Jun 1999
-
$3.29 B(+3.6%)
Mar 1999
-
$3.18 B(+6.3%)
Dec 1998
$2.99 B(+10.6%)
$2.99 B(-2.7%)
Sep 1998
-
$3.08 B(+13.4%)
Jun 1998
-
$2.71 B(-3.2%)
Mar 1998
-
$2.80 B(+3.6%)
Dec 1997
$2.70 B(+9.1%)
$2.70 B(-8.3%)
Sep 1997
-
$2.95 B(+10.2%)
Jun 1997
-
$2.67 B(+1.0%)
Mar 1997
-
$2.65 B(+6.9%)
Dec 1996
$2.48 B(+12.0%)
$2.48 B(+16.9%)
Sep 1996
-
$2.12 B(+8.0%)
Jun 1996
-
$1.96 B(-1.9%)
Mar 1996
-
$2.00 B(-9.5%)
Dec 1995
$2.21 B(-9.2%)
$2.21 B(-7.8%)
Sep 1995
-
$2.40 B(-3.7%)
Jun 1995
-
$2.49 B(+9.5%)
Mar 1995
-
$2.27 B(-6.6%)
Dec 1994
$2.44 B(-30.5%)
$2.44 B(-17.0%)
Sep 1994
-
$2.94 B(-15.4%)
Jun 1994
-
$3.47 B(-2.8%)
Mar 1994
-
$3.57 B(+1.8%)
Dec 1993
$3.50 B(+5.5%)
$3.50 B(-6.7%)
Sep 1993
-
$3.76 B(+0.8%)
Jun 1993
-
$3.73 B(+10.9%)
Mar 1993
-
$3.36 B(+1.2%)
Dec 1992
$3.32 B(+18.0%)
$3.32 B(+13.1%)
Sep 1992
-
$2.94 B(+7.6%)
Jun 1992
-
$2.73 B(-4.1%)
Mar 1992
-
$2.85 B(+1.1%)
Dec 1991
$2.81 B(-1.2%)
$2.81 B(-2.7%)
Sep 1991
-
$2.89 B(+6.0%)
Jun 1991
-
$2.73 B(-1.7%)
Mar 1991
-
$2.78 B(-2.5%)
Dec 1990
$2.85 B(-1.5%)
$2.85 B(-14.3%)
Sep 1990
-
$3.32 B(+3.0%)
Jun 1990
-
$3.23 B(+9.5%)
Mar 1990
-
$2.94 B(+1.8%)
Dec 1989
$2.89 B(+3.0%)
$2.89 B(+3.0%)
Dec 1988
$2.81 B(-2.4%)
$2.81 B(-2.4%)
Dec 1987
$2.88 B
$2.88 B

FAQ

  • What is Bristol-Myers Squibb annual working capital?
  • What is the all time high annual working capital for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual working capital year-on-year change?
  • What is Bristol-Myers Squibb quarterly working capital?
  • What is the all time high quarterly working capital for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly working capital year-on-year change?

What is Bristol-Myers Squibb annual working capital?

The current annual working capital of BMY is $9.51 B

What is the all time high annual working capital for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual working capital is $11.39 B

What is Bristol-Myers Squibb annual working capital year-on-year change?

Over the past year, BMY annual working capital has changed by +$4.13 B (+76.63%)

What is Bristol-Myers Squibb quarterly working capital?

The current quarterly working capital of BMY is $5.44 B

What is the all time high quarterly working capital for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly working capital is $29.70 B

What is Bristol-Myers Squibb quarterly working capital year-on-year change?

Over the past year, BMY quarterly working capital has changed by -$4.07 B (-42.82%)